Apex Molecular

Apex Molecular, formerly Yprotech, is a specialist chemical technology and process development (PD) company formed in April 2011 and based in Leeds, UK.

Apex Molecular is a synthetic chemistry company providing specialist services for the pharmaceutical, biotechnology (life sciences) and applied chemical sectors. They were established in 2011 and are based in the BioHub at Alderley Park.

Apex Molecular provide fast, reliable, cost effective delivery of chemistry development services for the life sciences and wider chemical sectors. They have an experienced management team with collectively over 65 years experience in the chemical and life sciences sectors. Additionally they have 40+ years chemistry experience across their key staff to ensure they select and apply the correct technology solution for their customer’s needs.

Apex Molecular also have particular expertise in use of precious metal catalysis and catalytic coupling chemistry, either using generic or proprietary homogeneous and supported catalysts. With a background of working with the pharmaceutical industry they are very aware of the need to supply high purity and high quality products.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.